Physicochemical Nature of SARS-CoV-2 Spike Protein Binding to Human Vimentin
Source abstract
Abstract
Vimentin, a protein that builds part of the cytoskeleton and is involved in many aspects of cellular function, was recently identified as a cell surface attachment site for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The present study investigated the physicochemical nature of the binding between the SARS-CoV-2 S1 glycoprotein receptor binding domain (S1 RBD) and human vimentin using atomic force microscopy and a quartz crystal microbalance. The molecular interactions of S1 RBD and vimentin proteins were quantified using vimentin monolayers attached to the cleaved mica or a gold microbalance sensor as well as in its native extracellular form present on the live cell surface. The presence of specific interactions between vimentin and S1 RBD was also confirmed using in silico studies. This work provides new evidence that cell-surface vimentin (CSV) functions as a site for SARS-CoV-2 virus attachment and is involved in the pathogenesis of Covid-19, providing a potential target for therapeutic countermeasures.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Virus-based gene therapy research · SARS-CoV-2 and COVID-19 Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Independent Laboratory of Nanomedicine, Medical University of Bialystok, PL-15222 Białystok, Poland
Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, PL-15222 Białystok, Poland
J. Haber Institute of Catalysis and Surface Chemistry Polish Academy of Science, Niezapominajek 8, PL-30239 Krakow, Poland
Institute of Nuclear Physics Polish Academy of Sciences, PL-31342 Krakow, Poland
Funding
Narodowe Centrum Nauki · Uniwersytet Medyczny w Bialymstoku
References (37)
Show source-provided references
1. 10.1002/rmv.220710.1002/rmv.2207 ↗
2. 10.1038/s41580-021-00418-x10.1038/s41580-021-00418-x ↗
3. 10.1073/pnas.200313811710.1073/pnas.2003138117 ↗
4. 10.1038/s41467-020-18319-610.1038/s41467-020-18319-6 ↗
5. 10.7554/eLife.6139010.7554/eLife.61390 ↗
6. 10.1186/s12929-016-0234-710.1186/s12929-016-0234-7 ↗
7. 10.1242/jcs.25059710.1242/jcs.250597 ↗
8. 10.3390/ijms2113467510.3390/ijms21134675 ↗
9. 10.1128/JVI.03826-1310.1128/JVI.03826-13 ↗
10. 10.3390/ijms2214746910.3390/ijms22147469 ↗
11. 10.1002/smll.20210564010.1002/smll.202105640 ↗
12. 10.1073/pnas.211387411910.1073/pnas.2113874119 ↗
13. 10.1021/acschembio.9b0006410.1021/acschembio.9b00064 ↗
14. 10.1038/s41586-020-2180-510.1038/s41586-020-2180-5 ↗
15. 10.1021/bc200099t10.1021/bc200099t ↗
16. 10.1021/la504975z10.1021/la504975z ↗
17. 10.1016/j.bios.2012.04.01410.1016/j.bios.2012.04.014 ↗
18. 10.1021/acs.biomac.2c0041510.1021/acs.biomac.2c00415 ↗
19. 10.1016/j.cocis.2018.11.00410.1016/j.cocis.2018.11.004 ↗
20. 10.3390/nano1101014510.3390/nano11010145 ↗
21. 10.1016/j.colsurfb.2015.11.05210.1016/j.colsurfb.2015.11.052 ↗
22. 10.1021/acs.jpcc.6b0268310.1021/acs.jpcc.6b02683 ↗
23. 10.1039/c3sm52257a10.1039/c3sm52257a ↗
24. 10.1126/science.34757510.1126/science.347575 ↗
25. 10.1016/S0006-3495(95)80441-810.1016/S0006-3495(95)80441-8 ↗
26. 10.1038/ncomms546310.1038/ncomms5463 ↗
27. 10.1038/s41467-019-12411-210.1038/s41467-019-12411-2 ↗
28. 10.1126/sciadv.aat127310.1126/sciadv.aat1273 ↗
29. 10.1016/j.jmb.2021.16705110.1016/j.jmb.2021.167051 ↗
30. 10.1016/j.jmb.2021.16705810.1016/j.jmb.2021.167058 ↗
31. 10.1016/j.str.2015.05.00610.1016/j.str.2015.05.006 ↗
32. 10.1016/j.bpj.2020.10.04810.1016/j.bpj.2020.10.048 ↗
33. 10.1038/s41586-021-03819-210.1038/s41586-021-03819-2 ↗
34. 10.1016/j.jmb.2015.09.01410.1016/j.jmb.2015.09.014 ↗
35. 10.1093/nar/gky47310.1093/nar/gky473 ↗
36. 10.1093/nar/gki38710.1093/nar/gki387 ↗
37. 10.1002/jcc.2008410.1002/jcc.20084 ↗